Mayet W J, Schwarting A, Orth T, Duchmann R, Meyer zum Büschenfelde K H
I. Medical Department, University of Mainz, Germany.
Clin Exp Immunol. 1996 Feb;103(2):259-67. doi: 10.1046/j.1365-2249.1996.d01-626.x.
VCAM-1 was first identified as an adhesion molecule induced on human endothelial cells (HEC) by inflammatory cytokines such as IL-1, tumour necrosis factor (TNF), and lipopolysaccharide (LPS). The molecule binds to a variety of leucocytes, including B cells, T cells, basophils, eosinophils and monocytes. Vascular expression of VCAM-1 has been associated with a number of disease states, including rheumatoid arthritis and vasculitis. The detection of anti-neutrophil cytoplasmic antibodies (ANCA), especially to proteinase 3 (PR3), has become important in the diagnosis of Wegener's granulomatosis (WG) and related vasculitides. Recently we were able to demonstrate a direct effect of anti-PR3 antibodies on neutrophil-endothelial interactions (Blood 1993; 82:1221). Binding of anti-PR3 antibodies to their antigen translocated into the membrane of HEC leads to an enhanced adhesion of neutrophils via induction of E-selectin (Clin Exp Immunol 1993; 94:440). The aim of this study was to investigate the effect of anti-PR3 antibodies on the expression of VCAM-1. HEC were isolated from umbilical vein and cultured on microtitre plates. After preincubation with purified anti-PR3 antibody, purified control antibodies (SS-A, SS-B, RNP) (IgG and F(ab')2 fragments) or different cytokines (controls), VCAM-1 was detected on the surface of unfixed HEC by cyto-ELISA and polymerase chain reaction analysis. Incubation of HEC with anti-PR3 antibodies led to a marked increase of endothelial VCAM-1 expression with a peak after 8 h. Incubation with TNF-alpha also led to maximal VCAM-1 expression after 4-6 h (control). Increased adhesion of T lymphocytes to HEC after binding of anti-PR3 antibodies to their antigen could be confirmed by performing adherence assays. This effect could be inhibited by antibodies to VLA-4. In conclusion, we have been able to show that cytokine-like effects of anti-PR3 antibodies on HEC are not limited to induction of neutrophil adhesion. Anti-PR3 antibodies may thus contribute to the regulation of T lymphocyte migration from the blood by HEC in ANCA-related vasculitides.
血管细胞黏附分子-1(VCAM-1)最初被鉴定为一种由白细胞介素-1、肿瘤坏死因子(TNF)和脂多糖(LPS)等炎性细胞因子诱导人内皮细胞(HEC)产生的黏附分子。该分子可与多种白细胞结合,包括B细胞、T细胞、嗜碱性粒细胞、嗜酸性粒细胞和单核细胞。VCAM-1的血管表达与多种疾病状态相关,包括类风湿性关节炎和血管炎。抗中性粒细胞胞浆抗体(ANCA)的检测,尤其是针对蛋白酶3(PR3)的检测,在韦格纳肉芽肿(WG)及相关血管炎的诊断中变得至关重要。最近我们能够证明抗PR3抗体对中性粒细胞与内皮细胞相互作用有直接影响(《血液》1993年;82:1221)。抗PR3抗体与其转移至HEC膜上的抗原结合后,通过诱导E-选择素导致中性粒细胞黏附增强(《临床与实验免疫学》1993年;94:440)。本研究的目的是探讨抗PR3抗体对VCAM-1表达的影响。从脐静脉分离出HEC并培养于微量滴定板上。在用纯化的抗PR3抗体、纯化的对照抗体(SS-A、SS-B、RNP)(IgG和F(ab')2片段)或不同细胞因子(对照)进行预孵育后,通过细胞酶联免疫吸附测定(cyto-ELISA)和聚合酶链反应分析在未固定的HEC表面检测VCAM-1。用抗PR3抗体孵育HEC导致内皮VCAM-1表达显著增加,8小时后达到峰值。用肿瘤坏死因子-α孵育在4 - 6小时后也导致VCAM-1表达达到最大值(对照)。通过进行黏附试验可以证实抗PR3抗体与其抗原结合后T淋巴细胞与HEC的黏附增加。这种作用可被抗VLA-4抗体抑制。总之,我们已经能够表明抗PR3抗体对HEC的细胞因子样作用不仅限于诱导中性粒细胞黏附。因此,抗PR3抗体可能在ANCA相关血管炎中有助于调节HEC介导的T淋巴细胞从血液中的迁移。